Genetic findings in schizophrenia patients related to alterations in the intracellular Ca-homeostasis

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 8, 2010, Pages 1375-1380

  Giegling, Ina ^a   Genius, Just ^a   Benninghoff, Jens ^a   Rujescu, Dan ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Calcium; Genetics; GWA; NMDA; Schizophrenia; SNP

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM ION; DEXTRO AMINO ACID OXIDASE; DEXTRO AMINO ACID OXIDASE ACTIVATOR; DYSBINDIN; ENZYME ACTIVATOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; NEUROGRANIN; NEURONAL NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT CALCIUM CHANNEL L TYPE ALPHA 1C SUBUNIT;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; DOPAMINERGIC TRANSMISSION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HERITABILITY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; RISK ASSESSMENT; SCHIZOPHRENIA; SEROTONINERGIC TRANSMISSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CALCIUM; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMEOSTASIS; HUMANS; INTRACELLULAR FLUID; SCHIZOPHRENIA;

EID: 78649498606     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.06.018     Document Type: Article

References (71)

1. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008, 40(7):827-834. [Jul].
2. Bassett A.S., McGillivray B.C., Jones B.D., Pantzar J.T. Partial trisomy chromosome 5 cosegregating with schizophrenia. Lancet 1988, 1(8589):799-801. [Apr 9].
3. Behrens M.M., Sejnowski T.J. Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?. Neuropharmacology 2009, 57(3):193-200. [Sep].
4. Benzel I., Bansal A., Browning B.L., Galwey N.W., Maycox P.R., McGinnis R., et al. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct 2007, 3:31. [Jun 28].
5. Bertolino A., Esposito G., Callicott J.H., Mattay V.S., Van Horn J.D., Frank J.A., et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 2000, 157(1):26-33.
6. Boks M.P., Rietkerk T., van de Beek M.H., Sommer I.E., de Koning T.J., Kahn R.S. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol 2007, 17(9):567-572. [Sep].
7. Braun I., Genius J., Grunze H., Bender A., Möller H.J., Rujescu D. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr Res 2008, 97(1-3):254-263.
8. Britsch S. The neuregulin-I/ErbB signaling system in development and disease. Adv Anat Embryol Cell Biol 2007, 190:1-65. [Review].
9. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999, 56:162-168.
10. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002, 99(21):13675-13680. [Oct 15].
11. Corvin A.P., Morris D.W., McGhee K., Schwaiger S., Scully P., Quinn J., et al. Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs. 97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 2004, 9(2):208-213. [Feb].
12. Dickman D.K., Davis G.W. The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis. Science 2009, 326(5956):1127-1130. [Nov 20].
13. Donohoe G., Walters J., Morris D.W., Quinn E.M., Judge R., Norton N., et al. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. Arch Gen Psychiatry 2009, 66(10):1045-1054. [Oct].
14. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008, 40(9):1056-1058. Wellcome Trust Case Control Consortium, [Sep].
15. Gao X.M., Sakai K., Roberts R.C., Conley R.R., Dean B., Tamminga C.A. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 2000, 157(7):1141-1149.
16. Gong Y.G., Wu C.N., Xing Q.H., Zhao X.Z., Zhu J., He L. A two-method meta-analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia. Schizophr Res 2009, 111(1-3):109-114. [Jun].
17. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 2009, [Jul 21, Electronic publication ahead of print].
18. Grunze H., Bender A., Wendhof S., Schäfer M., Rujescu D. Neurotoxicity of NMDA antagonists. A glutamatergic theory of schizophrenia based on selective impairment of local inhibitory feedback circuits. Dialogues Clin Neurosci 2000, 2(3):287-298.
19. Guo A.Y., Sun J., Riley B.P., Thiselton D.L., Kendler K.S., Zhao Z. The dystrobrevin-binding protein 1 gene: features and networks. Mol Psychiatry 2009, 14(1):18-29. [Jan].
20. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 2006, 12(7):824-828. [Jul].
21. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A., Yang D.J., Xiong W.C., Salter M.W., Mei L. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000, 26(2):443-455. [May].
22. Kennedy J.L., Giuffra L.A., Moises H.W., Cavalli-Sforza L.L., Pakstis A.J., Kidd J.R., et al. Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature 1988, 336(6195):167-170. [Nov 10].
23. Kornau H.C., Seeburg P.H., Kennedy M.B. Interaction of ion channels and receptors with PDZ domain proteins. Curr Opin Neurobiol 1997, 7(3):368-373. [Jun, Review].
24. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994, 51:199-214.
25. Kubota Y., Putkey J.A., Waxham M.N. Neurogranin controls the spatiotemporal pattern of postsynaptic Ca2+/CaM signaling. Biophys J 2007, 93(11):3848-3859. [Dec 1, Electronic publication 2007 Aug 17].
26. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 1995, 13(1):9-19.
27. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, Part II: Schizophrenia. Am J Hum Genet 2003, 73(1):34-48. [Jul].
28. Li D., He L. Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis. Schizophr Res 2007, 96(1-3):112-118. [Nov].
29. Li D., Collier D.A., He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 2006, 15(12):1995-2002. [Jun 15].
30. Li B., Woo R.S., Mei L., Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007, 54(4):583-597. [May 24].
31. Lichtenstein P., Yip B.H., Björk C., Pawitan Y., Cannon T.D., Sullivan P.F., et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239. [Jan 17].
32. Lidow M.S. Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Brain Res Rev 2003, 43(1):70-84. [Sep].
33. Liou Y.J., Tsai S.J., Hong C.J., Liao D.L. Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia. Schizophr Res 2003, 65(1):57-59. [Dec 1].
34. Maher B.S., Reimers M.A., Riley B.P., Kendler K.S. Allelic heterogeneity in genetic association meta-analysis: an application to DTNBP1 and schizophrenia. Hum Hered 2010, 69(2):71-79.
35. Malhotra A.K., Pinals D.A., Weingartner H., Sirocco K., Missar C.D., Pickar D., et al. NMDA receptor function and human cognition-the effects of ketamine in healthy volunteers. Neuropsychopharmacology 1996, 14:301-307.
36. Malhotra A.K., Pinals D.A., Adler C.M., Elman I., Clifton A., Pickar D., et al. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 1997, 17(3):141-150.
37. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436.
38. Morris D.W., McGhee K.A., Schwaiger S., Scully P., Quinn J., Meagher D., et al. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr Res 2003, 60(2-3):167-172. [Apr 1].
39. Munafò M.R., Thiselton D.L., Clark T.G., Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 2006, 11(6):539-546. [Jun, Review].
40. Munafò M.R., Attwood A.S., Flint J. Neuregulin 1 genotype and schizophrenia. Schizophr Bull 2008, 34(1):9-12. [Jan].
41. Ng M.Y., Levinson D.F., Faraone S.V., Suarez B.K., DeLisi L.E., Arinami T., et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 2009, 14(8):774-785. [Aug].
42. Nicodemus K.K., Luna A., Vakkalanka R., Goldberg T., Egan M., Straub R.E., et al. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry 2006, 11(12):1062-1065. [Dec].
43. Norton N., Moskvina V., Morris D.W., Bray N.J., Zammit S., Williams N.M., et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006, 141B(1):96-101. [Jan 5].
44. Nyegaard M., Demontis D., Foldager L., Hedemand A., Flint T.J., Sørensen K.M., et al. CACNA1C (rs1006737) is associated with schizophrenia. Mol Psychiatry 2010, 15(2):119-121. [Feb].
45. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008, 40(9):1053-1055. [Sep].
46. Owen M.J., Williams H.J., O'Donovan M.C. Schizophrenia genetics: advancing on two fronts. Curr Opin Genet Dev 2009, 19(3):266-270. [Jun].
47. Reif A., Herterich S., Strobel A., Ehlis A.C., Saur D., Jacob C.P., et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 2006, 11(3):286-300. [Mar].
48. Reynolds G.P., Beasley C.L. GABAergic neuronal subtypes in the human frontal cortex-development and deficits in schizophrenia. J Chem Neuroanat 2001, 22(1-2):95-100.
49. Rujescu D., Bender A., Keck M., Hartmann A.M., Ohl F., Raeder H., et al. A pharmacological model for psychosis based on NMDA receptor hypofunction. Molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 2006, 59:721-729.
50. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C., et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 2004, 9(2):203-207. [Feb].
51. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003, 72(1):185-190.
52. Sherrington R., Brynjolfsson J., Petursson H., Potter M., Dudleston K., Barraclough B., et al. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 1988, 336(6195):164-167. [Nov 10].
53. Shi J., Badner J.A., Gershon E.S., Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res 2008, 98(1-3):89-97. [Jan].
54. Shi J., Gershon E.S., Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res 2008, 104(1-3):96-107. [Sep].
55. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757. [Aug 6].
56. Shinkai T., Ohmori O., Hori H., Nakamura J. Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry 2002, 7(6):560-563.
57. Shiota S., Tochigi M., Shimada H., Ohashi J., Kasai K., Kato N., et al. Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population. J Hum Genet 2008, 53(10):929-935.
58. Silberberg G., Darvasi A., Pinkas-Kramarski R., Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet 2006, 141B(2):142-148. [Mar 5].
59. Sklar P., Smoller J.W., Fan J., Ferreira M.A., Perlis R.H., Chambert K., et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008, 13(6):558-569. [Jun].
60. Snyder S.H., Ferris C.D. Novel neurotransmitters and their neuropsychiatric relevance. Am J Psychiatry 2000, 157(11):1738-1751. [Nov, Review].
61. So H.C., Fong P.Y., Chen R.Y., Hui T.C., Ng M.Y., Cherny S.S., et al. Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population. Am J Med Genet B Neuropsychiatr Genet 2010, 153B(1):103-113. [Jan 5].
62. St Clair D., Blackwood D., Muir W., Baillie D., Hubbard A., Wright A., et al. No linkage of chromosome 5q11-q13 markers to schizophrenia in Scottish families. Nature 1989, 339(6222):305-309. May 25.
63. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002, 71(4):877-892. [Oct].
64. Stefansson H., Sarginson J., Kong A., Yates P., Steinthorsdottir V., Gudfinnsson E., et al. St Clair D. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003, 72(1):83-87. [Jan].
65. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D. Common variants conferring risk of schizophrenia. Nature 2009, 460(7256):744-747. [Aug 6].
66. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002, 71(2):337-348. [Aug].
67. Tang W., Huang K., Tang R., Zhou G., Fang C., Zhang J. Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population. Int J Neuropsychopharmacol 2008, 11(8):1063-1071. [Dec, Electronic publication 2008 Jun 11].
68. Wang X., He G., Gu N., Yang J., Tang J., Chen Q., et al. Association of G72/G30 with schizophrenia in the Chinese population. Biochem Biophys Res Commun 2004, 319(4):1281-1286. [Jul 9].
69. Wellcome Trust Case Control Consortium Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007, 447(7145):661-678. [Jun 7].
70. Wen L., Lu Y.S., Zhu X.H., Li X.M., Woo R.S., Chen Y.J., et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci USA 2010, 107(3):1211-1216. [Jan 19].
71. Williams H.J., Owen M.J., O'Donovan M.C. Schizophrenia genetics: new insights from new approaches. Br Med Bull 2009, 91:61-74.